Ipsen

Ipsen

China - Tianjin
Biotechnology

Focus: Small Molecules, Biologics

Ipsen is a life sciences company focused on Small Molecules, Biologics.

OncologyEndocrinologyNeurologyGastroenterologyMetabolic Diseases
Employees
1001-5000
Open Jobs
0

Products & Portfolio (7)

2 discontinued products not shown

BYLVAY
odevixibat
Peak
ORAL · CAPSULE
Ileal Bile Acid Transporter Inhibitors
pruritus in patients 3 months of ageolder with PFICcholestatic pruritus in patients 12 months of age+1 more
2021
0
DYSPORT
botulinum toxin type a
LOE Approaching
INJECTION · INJECTABLE
Acetylcholine Release Inhibitors
cervical dystonia in adultsspasticity in patients 2 years of ageolder
2009
30
INCRELEX
mecasermin
LOE Approaching
SUBCUTANEOUS · INJECTABLE
Insulin-like growth factor-1 (IGF-1) is a key hormonal mediator on statural growth. Under normal circumstances, growth hormone (GH) binds to its receptor in the liver, and other tissues, and stimulates the synthesis/secretion of IGF-1. In target tissues, the Type 1 IGF-1 receptor, which is homologous to the insulin receptor, is activated by IGF-1, leading to intracellular signaling which stimulates multiple processes resulting in statural growth. The metabolic actions of IGF-1 are in part directed at stimulating the uptake of glucose, fatty acids, and amino acids so that metabolism supports growing tissues.
growth failure in pediatric patients 2 years of ageolder with severe primary IGF-1 deficiencygrowth hormone (GH) gene deletion+1 more
2005
30
IQIRVO
elafibranor
Growth
ORAL · TABLET
Peroxisome Proliferator-activated Receptor Agonists
2024
0
ONIVYDE
irinotecan hydrochloride
Peak
INTRAVENOUS · INJECTABLE, LIPOSOMAL
1 inhibitor encapsulated in a lipid bilayer vesicle or liposome. Topoisomerase 1 relieves torsional strain in DNA by inducing single-strand breaks. Irinotecan and its active metabolite SN-38 bind reversibly to the topoisomerase 1-DNA complex and prevent re-ligation of the single-strand breaks, leading to exposure time-dependent double-strand DNA damage and cell death. In mice bearing human tumor xenografts, irinotecan liposome administered at irinotecan HCl-equivalent doses 5-fold lower than irinotecan HCl achieved similar intratumoral exposure of SN-38.
2015
0
SOHONOS
palovarotene
Growth
ORAL · CAPSULE
FOP, abnormal bone formation, including heterotopic ossification (HO), is driven by a gain-of-function mutation in the bone morphogenetic protein (BMP) type I receptor ALK2 (ACVR1). Palovarotene is an orally bioavailable retinoic acid receptor agonist, with particular selectivity at the gamma subtype of RAR. Through binding to RARγ, palovarotene decreases the BMP/ALK2 downstream signaling pathway by inhibiting the phosphorylation of SMAD1/5/8, which reduces ALK2/SMAD-dependent chondrogenesis and osteocyte differentiation resulting in reduced endochondral bone formation.
2023
0
SOMATULINE DEPOT
lanreotide acetate
LOE Approaching
PeptideSUBCUTANEOUS · SOLUTION
2007
30

Pipeline & Clinical Trials

Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptor
Prostate Cancer
N/A
Clinical Trials (1)
NCT04593420Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.
N/A
Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or M
Advanced Renal Cell Carcinoma
N/A
Clinical Trials (1)
NCT03647878Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
N/A
Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Acromegaly
N/A
Clinical Trials (1)
NCT00686348Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
N/A
Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke
Upper Limb Spasticity Post-Stroke
N/A
Clinical Trials (1)
NCT02384330Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke
N/A
Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
Spasticity
N/A
Clinical Trials (1)
NCT01444794Adult Subjects Suffering From Lower Limb Spasticity Following Stroke
N/A
Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
Acromegaly
N/A
Clinical Trials (1)
NCT02012127Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
N/A
Botulinum toxin type A
Lower Limb Spasticity
N/A
Clinical Trials (1)
NCT02020980RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke
N/A
Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real
Adult Lower Limb Spasticity
N/A
Clinical Trials (1)
NCT04050527Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort
N/A
IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population
IGF-1 Deficiency
N/A
Clinical Trials (1)
NCT01676090IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population
N/A
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
Renal Cell Carcinoma
N/A
Clinical Trials (1)
NCT03776123Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
N/A
A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Fam
Progressive Familial Intrahepatic Cholestasis
N/A
Clinical Trials (1)
NCT07185919A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea
N/A
Data collection
Ulcerative Colitis
N/A
Clinical Trials (1)
NCT03689673Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)
N/A
A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, Grip
Upper Limb Spasticity (ULS)
N/A
Clinical Trials (1)
NCT05169775A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).
N/A
Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromega
Acromegaly
N/A
Clinical Trials (1)
NCT05184231Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China
N/A
A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for H
Neuroendocrine Tumors
N/A
Clinical Trials (1)
NCT01234168A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
N/A
Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients
Cervical Dystonia
N/A
Clinical Trials (1)
NCT01840462Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]
N/A
Somatuline Autogel® 60, 90 or 120 mg
Acromegaly
N/A
Clinical Trials (1)
NCT01840449Somatuline Predictive Factors in Acromegaly and NET
N/A
Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real
Upper Limb Spasticity
N/A
Clinical Trials (1)
NCT02454803Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
N/A
This is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician.
Gastroenteropancreatic Neuroendocrine Tumors
N/A
Clinical Trials (1)
NCT02630654Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs
N/A
Data collection
Spasticity, Muscle
N/A
Clinical Trials (1)
NCT03442660Validation of the Spasticity Related Quality of Life Questionnaire
N/A
platinum chemotherapy
Neuroendocrine Tumors
N/A
Clinical Trials (1)
NCT04365023Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors
N/A
N/A
Clinical Trials (1)
NCT02231593SAGIT for Classification of Patients With Acromegaly in Clinical Practice
N/A
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Dis
Acromegaly
N/A
Clinical Trials (1)
NCT00500227Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
N/A
Clinical Trials (1)
NCT03874455Tazemetostat Expanded Access Program for Adults With Solid Tumors
N/A
Abobotulinum toxin A
Tourette Syndrome
N/A
Clinical Trials (1)
NCT02187679Pilot Study for Use of Dysport in Treatment of Vocal Tics in Patients With Tourette's Syndrome
N/A
Data collection
Internal Endometriosis
N/A
Clinical Trials (1)
NCT03586063Study of Diphereline 3.75 mg Treatment In Women Suffering From Internal Genital Endometriosis
N/A
Eziclen®/Izinova®
Bowel Cleansing
N/A
Clinical Trials (1)
NCT02630680Eziclen Drug Utilisation in Real Life Setting
N/A
Non-interventional cross-sectional survey
Acromegaly
N/A
Clinical Trials (1)
NCT02020967Programme of Acromegaly Screening in Patients With Associated Somatic Disorders
N/A
mecasermin [rDNA origin] injection
Primary Insulin-like Growth Factor-1 Deficiency
N/A
Clinical Trials (1)
NCT00747604IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex
N/A
Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in
Acromegaly
N/A
Clinical Trials (1)
NCT05431803Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China
N/A
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therap
Follicular Lymphoma
N/A
Clinical Trials (1)
NCT07282548Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies
N/A
Triptorelin Acetate 3.75mg intramuscular injection
Deep Infiltrating Endometriosis (DIE)
N/A
Clinical Trials (1)
NCT01942369A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months
N/A
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixiba
Pregnancy Related
N/A
Clinical Trials (1)
NCT06258902Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
N/A
Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In
Spasticity
N/A
Clinical Trials (1)
NCT04446702Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA
N/A
A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Pa
Fibrodysplasia Ossificans Progressiva
N/A
Clinical Trials (1)
NCT06089616A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
N/A
A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrah
PFIC - Progressive Familial Intrahepatic Cholestasis
N/A
Clinical Trials (1)
NCT07191704A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain
N/A
Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg
Acromegaly
N/A
Clinical Trials (1)
NCT02698384Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg
N/A
Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroen
Gastrointestinal Neuroendocrine Tumours
N/A
Clinical Trials (1)
NCT02853422Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours
N/A
CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients
Upper Limb Injury
N/A
Clinical Trials (1)
NCT06245772CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity
N/A
Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer
Prostate Cancer
N/A
Clinical Trials (1)
NCT02853409Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer
N/A
Clinical Trials (1)
NCT04624828Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT
N/A
Clinical Trials (1)
NCT04353765Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors
N/A
A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in
Advanced Renal Cell Carcinoma
N/A
Clinical Trials (1)
NCT03696407A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK
N/A
United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Sett
Neuroendocrine Tumours (NET)
N/A
Clinical Trials (1)
NCT04649580United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting
N/A
A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrin
Neuroendocrine Tumors
N/A
Clinical Trials (1)
NCT05922579A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET
N/A
DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia
Cervical Dystonia
N/A
Clinical Trials (1)
NCT01314365DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia
N/A
A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real
Spasticity Related to Any Cause Except Cerebral Palsy
N/A
Clinical Trials (1)
NCT04396704A Study to Assess Treatment Outcomes of abobotulinumtoxinA and onabotulinumtoxinA Treatments in Real Life Practice in Toxin-naïve Adult Patients With Limb Spasticity.
N/A
Bimanual 3D Motion Analysis " Be-API "
Unilateral Spastic Cerebral Palsy
N/A
Clinical Trials (1)
NCT03888443"Be an Airplane Pilot": A Bimanual 3D Motion Analysis in Children With Unilateral Cerebral Palsy
N/A
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Tre
Neuroendocrine Tumors
N/A
Clinical Trials (1)
NCT07314164Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
N/A
Community-based Neuroendocrine Tumor (NET) Research Study
Gastroenteropancreatic Neuroendocrine Tumors
N/A
Clinical Trials (1)
NCT02730104Community-based Neuroendocrine Tumor (NET) Research Study
N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 1986
Portfolio: 9 approved products, 150 clinical trials
Top TAs: Oncology, Endocrinology, Neurology
Portfolio Health
Growth2 (22%)
Peak2 (22%)
LOE Approaching3 (33%)
Post-LOE2 (22%)
9 total products
Therapeutic Area Focus
Oncology
164 pipeline
Endocrinology
1 marketed42 pipeline
Neurology
1 marketed24 pipeline
Gastroenterology
17 pipeline
Nephrology
5 pipeline
Women's Health
5 pipeline
Metabolic Diseases
2 marketed2 pipeline
Rare Diseases
4 pipeline
Marketed
Pipeline

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles